Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis

Detalhes bibliográficos
Autor(a) principal: Feitoza, Carla Q. [UNIFESP]
Data de Publicação: 2008
Outros Autores: Gonalves, Giselle M. [UNIFESP], Semedo, Patricia [UNIFESP], Cenedeze, Marcos A. [UNIFESP], Pinheiro, Helady S., Beraldo, Felipe Caetano, Santos, Oscar Fernando Pavao dos [UNIFESP], Teixeira, Vicente de Paula A., Reis, Marlene A. dos, Mazzali, Marilda, Pacheco-Silva, Alvaro [UNIFESP], Camara, Niels O. S. [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://molmed.org/journal/articles/3/1228
http://repositorio.unifesp.br/handle/11600/30985
Resumo: Ischemia and reperfusion injury (IRI) contributes to the development of chronic interstitial fibrosis/tubular atrophy in renal allograft patients, Cyclooxygenase (COX) 1 and 2 actively participate in acute ischemic injury by activating endothelial cells and inducing oxidative stress. Furthermore, blockade of COX I and 2 has been associated with organ improvement after ischemic damage. the aim of this study was to evaluate the role of COX I and 2 in the development of fibrosis by performing a COX I and 2 blockade immediately before IRI We subjected C57BI/6 male mice to 60 min of unilateral renal pedicle occlusion, Prior to surgery mice were either treated with indomethacin (IMT) at days -1 and 0 or were untreated. Blood and kidney samples were collected 6 wks after IRI. Kidney samples were analyzed by real-time reverse transcription-poly me rase chain reaction for expression of transforming growth factor beta (TGF-beta), monocyte chemoattractant protein 1 (MCP-1), osteopontin (OPN), tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta, IL-10, heme oxygenose 1 (HO-1), vimentin, connective-tissue growth factor (CTGF), collagen 1, and bone morphogenic protein 7 (BMP-7), To assess tissue fibrosis we performed morphometric analyses and Sirius red staining. We also performed immunohistochemical analysis of anti-actin smooth muscle, Renal function did not significantly differ between groups. Animals pretreated with IMT showed significantly less interstitial fibrosis than nontreated animals. Gene transcript analyses showed decreased expression of TGF-beta, MCP-1,TNF-alpha, IL-1-beta, vimentin, collagen 1, CTGF and IL-10 mRNA (all P < 0.05), Moreover, HO-I mRNA was increased in animals pretreated with IMT (P < 0.05) Conversely, IMT treatment decreased osteopontin expression and enhanced BMP-7 expression, although these levels did rot reach statistical significance when compared with control expression levels, I he blockade of COX 1 and 2 resulted in less tissue fibrosis, which was associated with a decrease in proinflammatory cytokines and enhancement of the protective cellular response.
id UFSP_54d564dae7c662a1912891723b10ec9e
oai_identifier_str oai:repositorio.unifesp.br/:11600/30985
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of FibrosisIschemia and reperfusion injury (IRI) contributes to the development of chronic interstitial fibrosis/tubular atrophy in renal allograft patients, Cyclooxygenase (COX) 1 and 2 actively participate in acute ischemic injury by activating endothelial cells and inducing oxidative stress. Furthermore, blockade of COX I and 2 has been associated with organ improvement after ischemic damage. the aim of this study was to evaluate the role of COX I and 2 in the development of fibrosis by performing a COX I and 2 blockade immediately before IRI We subjected C57BI/6 male mice to 60 min of unilateral renal pedicle occlusion, Prior to surgery mice were either treated with indomethacin (IMT) at days -1 and 0 or were untreated. Blood and kidney samples were collected 6 wks after IRI. Kidney samples were analyzed by real-time reverse transcription-poly me rase chain reaction for expression of transforming growth factor beta (TGF-beta), monocyte chemoattractant protein 1 (MCP-1), osteopontin (OPN), tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta, IL-10, heme oxygenose 1 (HO-1), vimentin, connective-tissue growth factor (CTGF), collagen 1, and bone morphogenic protein 7 (BMP-7), To assess tissue fibrosis we performed morphometric analyses and Sirius red staining. We also performed immunohistochemical analysis of anti-actin smooth muscle, Renal function did not significantly differ between groups. Animals pretreated with IMT showed significantly less interstitial fibrosis than nontreated animals. Gene transcript analyses showed decreased expression of TGF-beta, MCP-1,TNF-alpha, IL-1-beta, vimentin, collagen 1, CTGF and IL-10 mRNA (all P < 0.05), Moreover, HO-I mRNA was increased in animals pretreated with IMT (P < 0.05) Conversely, IMT treatment decreased osteopontin expression and enhanced BMP-7 expression, although these levels did rot reach statistical significance when compared with control expression levels, I he blockade of COX 1 and 2 resulted in less tissue fibrosis, which was associated with a decrease in proinflammatory cytokines and enhancement of the protective cellular response.Universidade Federal de São Paulo, Div Nephrol, Expt & Clin Immunol Lab, São Paulo, BrazilUniv Fed Juiz de Fora, Div Nephrol, Juiz de Fora, MG, BrazilUniv Estadual Campinas, Div Nephrol, Campinas, SP, BrazilUniv Fed Triangulo Mineiro, Uberaba, MG, BrazilUniv São Paulo, Inst Biomed Sci 4, Dept Immunol, Transplantat Immunobiol Lab, BR-05508900 São Paulo, BrazilUniversidade Federal de São Paulo, Div Nephrol, Expt & Clin Immunol Lab, São Paulo, BrazilWeb of ScienceConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundacao de Amparo a Pesquisa of São PauloFundacao de Amparo a Pesquisa of São Paulo: 04/08311-4Fundacao de Amparo a Pesquisa of São Paulo: 04/13449-7Fundacao de Amparo a Pesquisa of São Paulo: 06/03982-5Fundacao de Amparo a Pesquisa of São Paulo: 07/07139-3Feinstein Inst Med ResUniversidade Federal de São Paulo (UNIFESP)Univ Fed Juiz de ForaUniversidade Estadual de Campinas (UNICAMP)Univ Fed Triangulo MineiroUniversidade de São Paulo (USP)Feitoza, Carla Q. [UNIFESP]Gonalves, Giselle M. [UNIFESP]Semedo, Patricia [UNIFESP]Cenedeze, Marcos A. [UNIFESP]Pinheiro, Helady S.Beraldo, Felipe CaetanoSantos, Oscar Fernando Pavao dos [UNIFESP]Teixeira, Vicente de Paula A.Reis, Marlene A. dosMazzali, MarildaPacheco-Silva, Alvaro [UNIFESP]Camara, Niels O. S. [UNIFESP]2016-01-24T13:51:49Z2016-01-24T13:51:49Z2008-11-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion724-730http://molmed.org/journal/articles/3/1228Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 11-12, p. 724-730, 2008.10.2119/2008-00064.Feitoza1076-1551http://repositorio.unifesp.br/handle/11600/30985WOS:000260980300008engMolecular Medicineinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2023-05-18T14:42:42Zoai:repositorio.unifesp.br/:11600/30985Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652023-05-18T14:42:42Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
title Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
spellingShingle Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
Feitoza, Carla Q. [UNIFESP]
title_short Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
title_full Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
title_fullStr Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
title_full_unstemmed Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
title_sort Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
author Feitoza, Carla Q. [UNIFESP]
author_facet Feitoza, Carla Q. [UNIFESP]
Gonalves, Giselle M. [UNIFESP]
Semedo, Patricia [UNIFESP]
Cenedeze, Marcos A. [UNIFESP]
Pinheiro, Helady S.
Beraldo, Felipe Caetano
Santos, Oscar Fernando Pavao dos [UNIFESP]
Teixeira, Vicente de Paula A.
Reis, Marlene A. dos
Mazzali, Marilda
Pacheco-Silva, Alvaro [UNIFESP]
Camara, Niels O. S. [UNIFESP]
author_role author
author2 Gonalves, Giselle M. [UNIFESP]
Semedo, Patricia [UNIFESP]
Cenedeze, Marcos A. [UNIFESP]
Pinheiro, Helady S.
Beraldo, Felipe Caetano
Santos, Oscar Fernando Pavao dos [UNIFESP]
Teixeira, Vicente de Paula A.
Reis, Marlene A. dos
Mazzali, Marilda
Pacheco-Silva, Alvaro [UNIFESP]
Camara, Niels O. S. [UNIFESP]
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Univ Fed Juiz de Fora
Universidade Estadual de Campinas (UNICAMP)
Univ Fed Triangulo Mineiro
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Feitoza, Carla Q. [UNIFESP]
Gonalves, Giselle M. [UNIFESP]
Semedo, Patricia [UNIFESP]
Cenedeze, Marcos A. [UNIFESP]
Pinheiro, Helady S.
Beraldo, Felipe Caetano
Santos, Oscar Fernando Pavao dos [UNIFESP]
Teixeira, Vicente de Paula A.
Reis, Marlene A. dos
Mazzali, Marilda
Pacheco-Silva, Alvaro [UNIFESP]
Camara, Niels O. S. [UNIFESP]
description Ischemia and reperfusion injury (IRI) contributes to the development of chronic interstitial fibrosis/tubular atrophy in renal allograft patients, Cyclooxygenase (COX) 1 and 2 actively participate in acute ischemic injury by activating endothelial cells and inducing oxidative stress. Furthermore, blockade of COX I and 2 has been associated with organ improvement after ischemic damage. the aim of this study was to evaluate the role of COX I and 2 in the development of fibrosis by performing a COX I and 2 blockade immediately before IRI We subjected C57BI/6 male mice to 60 min of unilateral renal pedicle occlusion, Prior to surgery mice were either treated with indomethacin (IMT) at days -1 and 0 or were untreated. Blood and kidney samples were collected 6 wks after IRI. Kidney samples were analyzed by real-time reverse transcription-poly me rase chain reaction for expression of transforming growth factor beta (TGF-beta), monocyte chemoattractant protein 1 (MCP-1), osteopontin (OPN), tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta, IL-10, heme oxygenose 1 (HO-1), vimentin, connective-tissue growth factor (CTGF), collagen 1, and bone morphogenic protein 7 (BMP-7), To assess tissue fibrosis we performed morphometric analyses and Sirius red staining. We also performed immunohistochemical analysis of anti-actin smooth muscle, Renal function did not significantly differ between groups. Animals pretreated with IMT showed significantly less interstitial fibrosis than nontreated animals. Gene transcript analyses showed decreased expression of TGF-beta, MCP-1,TNF-alpha, IL-1-beta, vimentin, collagen 1, CTGF and IL-10 mRNA (all P < 0.05), Moreover, HO-I mRNA was increased in animals pretreated with IMT (P < 0.05) Conversely, IMT treatment decreased osteopontin expression and enhanced BMP-7 expression, although these levels did rot reach statistical significance when compared with control expression levels, I he blockade of COX 1 and 2 resulted in less tissue fibrosis, which was associated with a decrease in proinflammatory cytokines and enhancement of the protective cellular response.
publishDate 2008
dc.date.none.fl_str_mv 2008-11-01
2016-01-24T13:51:49Z
2016-01-24T13:51:49Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://molmed.org/journal/articles/3/1228
Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 11-12, p. 724-730, 2008.
10.2119/2008-00064.Feitoza
1076-1551
http://repositorio.unifesp.br/handle/11600/30985
WOS:000260980300008
url http://molmed.org/journal/articles/3/1228
http://repositorio.unifesp.br/handle/11600/30985
identifier_str_mv Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 11-12, p. 724-730, 2008.
10.2119/2008-00064.Feitoza
1076-1551
WOS:000260980300008
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Molecular Medicine
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 724-730
dc.publisher.none.fl_str_mv Feinstein Inst Med Res
publisher.none.fl_str_mv Feinstein Inst Med Res
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268348028944384